abstract |
The present invention relates to the discovery of the particular heterocyclic compound (see formula I) and pharmaceutically acceptable salts thereof, possessing increased activity as mGluR5 antagonists. In addition, the present invention relates to therapeutic methods of use of these compounds for the treatment and prevention of various diseases and conditions. |